ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics Posted on August 23, 2024 by ARCA IT - Press Release, Uncategorized ARCA-Press-Release-Reverse-Stock-Split-FINALDownload
ARCA biopharma Declares Special Dividend in Connection with the Proposed Mergerwith Oruka Therapeutics Posted on August 22, 2024 by ARCA IT - Press Release, Uncategorized ARCA-Bio-Press-Release-Special-Dividend.-4882-8262-7543.3-FINALDownload
ARCA biopharma Announces Second Quarter 2024 Financial Results and Provides Corporate Update Posted on August 1, 2024 by ARCA IT - Press Release, Uncategorized 2024-Q2-Financial-Results-and-Business-Update-FinalDownload
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update Posted on April 25, 2024 by ARCA IT - Press Release, Uncategorized 2024-Q1-Financial-Results-and-Business-Update-FINALDownload
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement Posted on April 3, 2024 by ARCA IT - Press Release, Uncategorized ARCA-Oruka-Transaction-Merger-Release_FINALDownload
Arca Biopharma 10K December 31, 2023 Posted on February 1, 2024 by ARCA IT - Press Release, Uncategorized ABIO_10K_20231231-As-Filed-2.1.24-Print-ReadyDownload
ARCA biopharma Announces Third Quarter 2023 Financial Results Posted on October 19, 2023 by ARCA IT - Press Release, Uncategorized 2023-Q3-Financial-Results-and-Business-Update-FINALDownload
ARCA biopharma Announces Second Quarter 2022 Financial Results Posted on August 3, 2022 by ARCA IT - Press Release, Uncategorized 2022-Q2-Financial-Results-and-Business-Update-FINALDownload
JACOB MA-WEAVER JOINS ARCA BIOPHARMA BOARD OF DIRECTORS Posted on June 21, 2022 by ARCA IT - Press Release, Uncategorized 6.21-Jacob-Ma-Weaver-Joins-BOD-FINAL
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review Posted on May 5, 2022 by ARCA IT - Press Release, Uncategorized 5.4-ARCA-Retains-Ladenburg-Thalmann